NREL: 2020 was year of highlights for energy lab
GOLDEN -- National Renewable Energy Laboratory (NREL) researchers and staff reached many goals and achieved numerous successes in science, partnerships, and technology commercialization in 2020, from... Read More
Wednesday December 23, 2020 0 comments
Alpha Data announces Xilinx Versal ACAP accelerator board
GOLDEN and EDINBURGH, Scotland -- Alpha Data , a leading supplier of commercial off-the shelf FPGA solutions, announced the release of the ADM-PA100, the first deployable adaptive computing... Read More
Friday November 20, 2020 0 comments
NREL: Advanced manufacturing research moves wind turbine blades toward recyclability
GOLDEN -- A new material for wind blades that can be recycled could transform the wind industry, rendering renewable... Read More
Wednesday November 18, 2020 0 comments
Reven Pharmaceuticals reports positive results regarding clinical safety and preclinical efficacy of Its COVID-19 drug candidate Rejuveinix
GOLDEN -- Reven Holdings, Inc. today announced publication of a peer-reviewed article in the prestigious medical journal, Frontiers in Pharmacology, Section: Respiratory Pharmacology. In the... Read More
Thursday November 12, 2020 0 comments
Reven Pharmaceuticals wins FDA nod of IND application for COVID treatment with Rejuveinix
GOLDEN -- Reven today announced the U.S. Food and Drug Administration has approved its Investigational New Drug application in connection with its lead anti-inflammatory/anti-oxidant... Read More
Thursday October 22, 2020 0 comments
NREL, UK university partner to dive deeper into how enzymes digest plastic
GOLDEN -- A... Read More
Friday October 2, 2020 0 comments
Reven selects eClinical services provider DSG to accelerate Reven’s RJX as treatment for COVID-19
GOLDEN -- Reven Holdings, Inc. today announced it selected DSG, Inc., a leading global eClinical services provider, for all aspects of clinical trial data management during its upcoming COVID-19... Read More
Wednesday September 30, 2020 0 comments
Reven’s patented treatment platform for sepsis on track for testing COVID-19 patients
GOLDEN -- Reven Holdings, a privately held clinical stage biotechnology and pharmaceutical company dedicated to the discovery and development of novel treatment platforms for cancer, viral... Read More
Tuesday September 15, 2020 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
